1. Home
  2. SER vs GLBS Comparison

SER vs GLBS Comparison

Compare SER & GLBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$2.81

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Logo Globus Maritime Limited

GLBS

Globus Maritime Limited

HOLD

Current Price

$3.64

Market Cap

43.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SER
GLBS
Founded
2017
2006
Country
United States
Greece
Employees
16
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
42.0M
43.8M
IPO Year
2024
2010

Fundamental Metrics

Financial Performance
Metric
SER
GLBS
Price
$2.81
$3.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$15.00
$3.00
AVG Volume (30 Days)
40.9K
154.8K
Earning Date
05-14-2026
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$130,000.00
N/A
Revenue This Year
N/A
$13.06
Revenue Next Year
N/A
$20.20
P/E Ratio
N/A
N/A
Revenue Growth
132.14
N/A
52 Week Low
$1.22
$1.00
52 Week High
$7.92
$3.85

Technical Indicators

Market Signals
Indicator
SER
GLBS
Relative Strength Index (RSI) 74.64 63.91
Support Level $1.74 $1.43
Resistance Level $2.99 N/A
Average True Range (ATR) 0.16 0.28
MACD 0.07 0.06
Stochastic Oscillator 90.91 77.78

Price Performance

Historical Comparison
SER
GLBS

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

Share on Social Networks: